AI-generated summary
This review examined 22 preclinical studies in rats with partially injured tendons to assess photobiomodulation for tendinopathy. The authors report that the most common wavelengths were 660, 830, and 904 nm, and that results were heterogeneous, with few studies using mechanical outcomes. They conclude that photobiomodulation has potential to enhance tendon structure and function, but that variability in design and methods makes unified treatment parameters difficult to establish.
- Studies included
- 22
- Who or what was studied
- Rats with partially injured tendons (partially transected or partially traumatized) in in vivo animal studies
- Wavelengths
- 660, 830, 904 nm
- Limits stated in the abstract
- The abstract notes heterogeneity in study design, methods, light parameters and outcome measures, with most studies relying on a single assessment and only four reporting mechanical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
- Energy density (fluence)
- 17 J/cm2
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Tendinopathy, Heterogeneity, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.